Life Technologies (LIFE) may or may not find a deal to its liking and shuffle off the coil of publicly -traded companies. Consequently, investors shouldn't completely lose sight of the underlying fundamentals at this lead life sciences company. Those fundamentals are actually looking pretty good right now, though the chatter around a possible transaction has pushed the shares to a point where there's not much fundamental value left.
A Surprising Upturn In Growth...
Life Tech's results for the fourth quarter weren't that far off of the averaged sell-side estimates, but then they seldom are for this company. Revenue came in about 1% higher than expected, as the company saw 3% reported sales growth and organic growth of better...